RASSF1C inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of RASSF1C, one of the alternatively spliced isoforms of the Ras Association Domain Family 1 (RASSF1) gene. RASSF1 is involved in regulating critical cellular processes such as apoptosis, cell cycle progression, and cytoskeletal dynamics. Unlike the better-known RASSF1A isoform, RASSF1C has distinct regulatory functions and interacts with different sets of molecular partners. As a member of the RASSF1 family, RASSF1C plays a role in modulating cellular responses to external stimuli, particularly in pathways related to cell growth, differentiation, and apoptosis. Inhibitors of RASSF1C work by binding to its functional domains, thereby interfering with its ability to interact with key proteins and signaling pathways that regulate these processes.
The inhibition of RASSF1C leads to changes in the signaling pathways it influences, particularly those that manage cell growth and survival. By blocking RASSF1C's involvement in protein-protein interactions and downstream signaling cascades, these inhibitors prevent the normal regulation of cellular responses to environmental cues. This can result in altered cellular behavior, such as disruptions in cell cycle control, apoptosis, or cytoskeletal organization. Researchers use RASSF1C inhibitors to investigate the specific functions of this isoform in comparison to other RASSF1 family members, particularly to better understand the diversity of roles played by each isoform. These inhibitors help to shed light on the broader Ras-related pathways and their regulation by RASSF1C, offering insights into how specific isoforms contribute to fine-tuning cellular homeostasis and the balance between growth and programmed cell death. By studying RASSF1C inhibitors, scientists can gain deeper knowledge of the molecular mechanisms involved in cellular regulation, particularly in terms of how alternative splicing can produce functionally distinct proteins within the same gene family.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could downregulate RASSF1C by causing hypomethylation of its gene promoter, thereby leading to the suppression of its transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine may reduce RASSF1C levels by inhibiting DNA methyltransferases, which results in the demethylation of gene promoters including potentially that of RASSF1C. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid may decrease RASSF1C transcription by increasing the acetylation of histones associated with its gene, leading to a more open and less transcriptionally active chromatin structure. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A has the potential to inhibit RASSF1C expression by altering histone deacetylase activity, resulting in chromatin remodeling that can suppress gene transcription. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin could downregulate RASSF1C by inhibiting histone deacetylases, which may lead to a condensed chromatin structure around the RASSF1C gene, thus reducing its expression. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat may lead to a decrease in RASSF1C expression by inhibiting histone deacetylase enzymes, thereby affecting the chromatin accessibility for transcription factors. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid could inhibit RASSF1C by preventing the deacetylation of histones, which is essential for tight chromatin packing and suppression of gene transcription. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate could lead to the downregulation of RASSF1C by interfering with the folate pathway, thus reducing the methyl donor supply necessary for the methylation of its gene promoter. | ||||||
Hydralazine-15N4 Hydrochloride | 304-20-1 (unlabeled) | sc-490605 | 1 mg | $480.00 | ||
Hydralazine may decrease RASSF1C expression by inducing hypomethylation of DNA, including the promoter regions of genes such as RASSF1C. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram could lead to the downregulation of RASSF1C expression by inhibiting enzymes involved in DNA methylation and histone modification processes associated with gene silencing. | ||||||